End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.02 CNY | -0.36% | +10.53% | +2.70% |
Apr. 25 | Zhejiang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
2023 | Zhejiang Medicine Wins Nod to Trial Digestive Acid Drug | MT |
Sales 2024 * | 8.62B 1.19B | Sales 2025 * | 9.48B 1.31B | Capitalization | 10.56B 1.46B |
---|---|---|---|---|---|
Net income 2024 * | 476M 65.89M | Net income 2025 * | 637M 88.17M | EV / Sales 2024 * | 1.22 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.11 x |
P/E ratio 2024 * |
22.5
x | P/E ratio 2025 * |
16.7
x | Employees | 6,208 |
Yield 2024 * |
1.45% | Yield 2025 * |
2.09% | Free-Float | 58.54% |
1 day | -0.36% | ||
1 week | +10.53% | ||
Current month | +10.53% | ||
1 month | +21.37% | ||
3 months | +12.79% | ||
6 months | +0.73% | ||
Current year | +2.70% |
Managers | Title | Age | Since |
---|---|---|---|
Chun Lei Lu
CEO | Chief Executive Officer | 57 | 06-05-31 |
Nan Xing Li
BRD | Director/Board Member | 38 | 15-06-10 |
Ke Qiu
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chun Bo Li
CHM | Chairman | 65 | 97-04-30 |
Nai Wei Chen
BRD | Director/Board Member | 67 | 18-06-14 |
Chun Lei Lu
CEO | Chief Executive Officer | 57 | 06-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +7.24% | - | |
0.00% | 0 M€ | +3.63% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 11.02 | -0.36% | 57,245,100 |
24-05-09 | 11.06 | +2.12% | 24,629,840 |
24-05-08 | 10.83 | -1.72% | 21,965,320 |
24-05-07 | 11.02 | +2.13% | 38,406,300 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.70% | 1.46B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 600216 Stock